Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Black Men
100%
Disease Outcome
100%
Inflammatory Bowel Disease
100%
Racial Disparities
100%
Ulcerative Colitis
62%
Crohn's Disease
62%
White Patients
37%
Advanced Therapies
37%
Hospitalization
25%
Adalimumab
25%
United States
25%
Medical Therapy
25%
Medical Illness
25%
Ustekinumab
25%
Therapy Outcome
25%
Vedolizumab
25%
Tofacitinib
25%
Adjusted Odds Ratio
12%
Canada
12%
European Ancestry
12%
Corticosteroids
12%
Clostridium Difficile Infection
12%
Group-based
12%
Complex Disease
12%
Opioids
12%
Corticosteroid Use
12%
Disease Phenotype
12%
Patient-level
12%
Propensity Score Matching
12%
Missing Data
12%
Certolizumab
12%
Opioid Use
12%
Disease Complications
12%
Toxic Megacolon
12%
Lack of Information
12%
White European
12%
Inflammatory Bowel Disease Treatment
12%
Socioeconomic Strata
12%
Intestinal Fistula
12%
Perianal Fistula
12%
Perianal Abscess
12%
TriNetX
12%
Golimumab
12%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Diseases
100%
Ulcerative Colitis
55%
Crohn's Disease
55%
Combination Therapy
33%
Adalimumab
22%
Ustekinumab
22%
Vedolizumab
22%
Tofacitinib
22%
Infection
11%
Anus Fistula
11%
Toxic Megacolon
11%
Perianal Abscess
11%
Intestine Fistula
11%
Golimumab
11%